Video Upload Options

References

1. Alakus H, Yost SE, Woo B, French R, Lin GY, Jepsen K, Frazer KA, Lowy AM,Harismendy O. BAP1 mutation is a frequent somatic event in peritoneal malignantmesothelioma. J Transl Med. 2015 Apr 16;13:122. doi: 10.1186/s12967-015-0485-1.
2. Daou S, Hammond-Martel I, Mashtalir N, Barbour H, Gagnon J, Iannantuono NV,Nkwe NS, Motorina A, Pak H, Yu H, Wurtele H, Milot E, Mallette FA, Carbone M,Affar el B. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates CellProliferation and Is Disrupted in Cancer. J Biol Chem. 2015 Nov27;290(48):28643-63. doi: 10.1074/jbc.M115.661553.
3. Eletr ZM, Wilkinson KD. An emerging model for BAP1's role in regulating cellcycle progression. Cell Biochem Biophys. 2011 Jun;60(1-2):3-11. doi:10.1007/s12013-011-9184-6. Review.
4. Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM,Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD,Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ 3rd. BAP1: a novelubiquitin hydrolase which binds to the BRCA1 RING finger and enhancesBRCA1-mediated cell growth suppression. Oncogene. 1998 Mar 5;16(9):1097-112.
5. Kumar R, Taylor M, Miao B, Ji Z, Njauw JC, Jönsson G, Frederick DT, Tsao H.BAP1 has a survival role in cutaneous melanoma. J Invest Dermatol. 2015Apr;135(4):1089-1097. doi: 10.1038/jid.2014.528.
6. Matatall KA, Agapova OA, Onken MD, Worley LA, Bowcock AM, Harbour JW. BAP1deficiency causes loss of melanocytic cell identity in uveal melanoma. BMCCancer. 2013 Aug 5;13:371. doi: 10.1186/1471-2407-13-371.
7. Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, Leng N, Pavía-Jiménez A, Wang S,Yamasaki T, Zhrebker L, Sivanand S, Spence P, Kinch L, Hambuch T, Jain S, LotanY, Margulis V, Sagalowsky AI, Summerour PB, Kabbani W, Wong SW, Grishin N,Laurent M, Xie XJ, Haudenschild CD, Ross MT, Bentley DR, Kapur P, Brugarolas J.BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012 Jun10;44(7):751-9. doi: 10.1038/ng.2323. Erratum in: Nat Genet. 2012 Sep;44(9):1072.
8. Royer-Bertrand B, Torsello M, Rimoldi D, El Zaoui I, Cisarova K,Pescini-Gobert R, Raynaud F, Zografos L, Schalenbourg A, Speiser D, Nicolas M,Vallat L, Klein R, Leyvraz S, Ciriello G, Riggi N, Moulin AP, Rivolta C.Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing. Am J Hum Genet. 2016 Nov 3;99(5):1190-1198. doi: 10.1016/j.ajhg.2016.09.008.
9. Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG,Wilkinson KD. BRCA1-associated protein-1 is a tumor suppressor that requiresdeubiquitinating activity and nuclear localization. Cancer Res. 2008 Sep1;68(17):6953-62. doi: 10.1158/0008-5472.CAN-08-0365.
10. Yu H, Pak H, Hammond-Martel I, Ghram M, Rodrigue A, Daou S, Barbour H, CorbeilL, Hébert J, Drobetsky E, Masson JY, Di Noia JM, Affar el B. Tumor suppressor anddeubiquitinase BAP1 promotes DNA double-strand break repair. Proc Natl Acad Sci US A. 2014 Jan 7;111(1):285-90. doi: 10.1073/pnas.1309085110.